Position in GRAL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,810,967
+$2,010,591 QoQ
Shares Held
55,822
+60.2% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#58
of 374 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $104,115,596 across 9 Diagnostics & Research names. GRAL ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CDNA |
CareDx, Inc.
|
995,669 | $28,376,566 | |
| 2 | NTRA |
Natera, Inc.
|
94,577 | $25,672,926 | |
| 3 | FLGT |
Fulgent Genetics, Inc.
|
782,116 | $16,049,020 | |
| 4 | DHR |
Danaher Corp /De/
|
68,743 | $13,094,166 | |
| 5 | MYGN |
Myriad Genetics Inc
|
1,891,527 | $10,800,619 | |
| 6 | GH |
Guardant Health, Inc.
|
33,424 | $5,014,602 | |
| 7 | GRAL |
GRAIL, Inc.
This page
|
55,822 | $3,810,967 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
14,281 | $980,390 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,810,967 | 55,822 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,800,376 | 34,837 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,140,862 | 25,013 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,962,951 | 67,021 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $6,044,061 | 117,543 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,134,658 | 83,581 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,208,874 | 1,020,105 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $762,782 | 49,628 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||